Here are five notes:
1. Mr. Ishrak’s compensation at the end of the fiscal year totaled $40.5 million, according to a proxy.
2. Around $25.5 million of that was a tax gross-up payment coming out of the Medtronic-Covidien merger.
3. Mr. Ishrak earned $15 million this year before the tax gross-up, compared to $8.3 million he earned last year.
4. His annual incentive bonus was $5.6 million, up from $4.7 million last year.
5. The value of Mr. Ishrak’s restricted stock that vested increased from $2.1 million to $7.8 million.
More articles on devices:
SeaSpine adds leaders: 6 takeaways
Materialise, Lima Corporate sign agreement for 3D patient-specific surgical guides: 3 key notes
Amedica reveals expected Q2 2015 financial results, FDA response: 5 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
